SEOUL,South Korea,Feb. 19,2025-- Park Systems,a global leader in atomic force microscopy (AFM),has unveiled an expanded FX Large Sample AFM series at SEMICON Korea 2025. Building on the success of Pa
02-20
STAFFORD,Texas,Feb. 19,2025-- Microvast Holdings,Inc. (NASDAQ: MVST) ("Microvast" or the "Company"),a global leader in advanced battery technology,unveiled its next-generation high
02-20
SAN FRANCISCO,Feb. 19,2025-- Wrong-site surgery (WSS),a critical "Never Event," represents a failure that should never occur in healthcare. Yet,due to underreporting,the true prevalence of t
02-20
RIZHAO,China,Feb. 19,2025-- A news report from chinadaily.com.cn: Rizhao,located in East China\'s Shandong province,is advancing the high-quality integration of its port,industry,and city,charting a c
02-20
NEW YORK,Feb. 19,2025-- SunCar Technology Group Inc. ("SunCar" or the "Company") (NASDAQ: SDA),an innovative leader in auto e-insurance and cloud-based B2B auto services in China,t
02-20
HONG KONG,Feb. 20,2025-- Acclime,a leading provider of corporate,governance,and advisory services across Asia and key global markets,has established its fund services offering with the acquisition of
02-20
Forms strategic partnership with Korea Investment & Securities,signifying ambition to further grow CLI\'s private credit portfolio in South Korea
02-20
MUNICH and TOKYO,Feb. 19,2025-- Electrochaea and Hitachi have signed a five-year technology transfer and licensing agreement. Hitachi will deploy Electrochaea\'s patented technology to produce clean,s
02-20
MUNICH,Feb. 19,2025--On February 17,2025,GCL System Integration (GCL SI) achieved a significant milestone by securing the EcoVadis Group-level Silver Medal certification. In its first attempt,GCL SI s
02-20
Software and private wireless networks to see rising investment to underpin advanced technology deployments
02-20
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map
